Condition
Disorder Related to Cardiac Transplantation
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02347371CompletedPrimary
Heart Transplant Registry of Városmajor
NCT00377962Phase 4CompletedPrimary
Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation
NCT02503566Not ApplicableUnknownPrimary
Assessment of Cardiac Allograft Vasculopathy by Optical Coherence Tomography
Showing all 3 trials